Literature DB >> 24264061

High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter.

Takamichi Ishii1, Etsuro Hatano, Kentaro Yasuchika, Kojiro Taura, Satoru Seo, Shinji Uemoto.   

Abstract

PURPOSE: The relationship between the tumor size and organs of recurrence was analyzed to identify a high-risk group for the extrahepatic recurrence of hepatocellular carcinoma (HCC) after resection.
METHODS: A total of 544 patients with HCC underwent primary surgical resection for HCC between 2001 and 2010. Of these, 293 patients had a solitary tumor but no macroscopic vascular invasion. The prognostic factors for the overall survival and relapse-free survival were analyzed among these 293 patients. The recurrent organs and frequency of recurrence were also examined.
RESULTS: The analysis of the 293 patients showed that both the overall and relapse-free survival rates of the patients with a large tumor (>7 cm in diameter) were significantly worse than those of the patients with a tumor <7 cm. The incidence of lung metastasis was remarkably high in the group of patients with tumors more than 7 cm (24.0 %), in comparison to those with tumors <7 cm. A multivariate analysis revealed that the tumor size was the only independent risk factor for lung metastasis.
CONCLUSIONS: The patients with large HCC tumors more than 7 cm in diameter were at high-risk for a poor prognosis due to a high percentage of lung metastasis, even if there was no macroscopic vascular invasion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24264061     DOI: 10.1007/s00595-013-0792-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  New simple technique for hepatic parenchymal resection using a Cavitron Ultrasonic Surgical Aspirator and bipolar cautery equipped with a channel for water dripping.

Authors:  Y Yamamoto; I Ikai; M Kume; Y Sakai; A Yamauchi; H Shinohara; T Morimoto; Y Shimahara; M Yamamoto; Y Yamaoka
Journal:  World J Surg       Date:  1999-10       Impact factor: 3.352

2.  Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.

Authors:  S G Lee; S Hwang; J P Jung; Y J Lee; K H Kim; C S Ahn
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

3.  Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.

Authors:  Durgatosh Pandey; Kang-Hoe Lee; Chun-Tao Wai; Gajanan Wagholikar; Kai-Chah Tan
Journal:  Ann Surg Oncol       Date:  2007-08-10       Impact factor: 5.344

4.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

5.  Spontaneous regression of multiple pulmonary recurrences of hepatocellular carcinoma after hepatectomy: report of a case.

Authors:  Norifumi Harimoto; Ken Shirabe; Kiyoshi Kajiyama; Tomonobu Gion; Masaru Takenaka; Takashi Nagaie; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-03       Impact factor: 2.549

6.  Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

Authors:  Jae Min Chun; Hyung Jun Kwon; Junho Sohn; Sang Geol Kim; Ji-Young Park; Han Ik Bae; Young Kook Yun; Yoon Jin Hwang
Journal:  J Surg Oncol       Date:  2010-12-22       Impact factor: 3.454

7.  Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.

Authors:  Chong Zhong; Wei Wei; Xiao-Kang Su; Hui-Dong Li; Fa-Bing Xu; Rong-Ping Guo
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

8.  Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.

Authors:  Kojiro Taura; Iwao Ikai; Etsuro Hatano; Kentaro Yasuchika; Akio Nakajima; Masaharu Tada; Satoru Seo; Takafumi Machimoto; Shinji Uemoto
Journal:  Surgery       Date:  2007-11       Impact factor: 3.982

9.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

10.  Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Authors:  Ke Hao; John M Luk; Nikki P Y Lee; Mao Mao; Chunsheng Zhang; Mark D Ferguson; John Lamb; Hongyue Dai; Irene O Ng; Pak C Sham; Ronnie T P Poon
Journal:  BMC Cancer       Date:  2009-11-03       Impact factor: 4.430

View more
  11 in total

1.  Preventive Measures for Postoperative Bile Leakage After Central Hepatectomy: A Multicenter, Prospective, Observational Study of 101 Patients.

Authors:  Takamichi Ishii; Etsuro Hatano; Hiroaki Furuyama; Dai Manaka; Hiroaki Terajima; Shinji Uemoto
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

Review 2.  Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.

Authors:  Neda Amini; Aslam Ejaz; Gaya Spolverato; Shishir K Maithel; Yuhree Kim; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-10-10       Impact factor: 3.452

3.  Our technique of preceding diaphragm resection and partial mobilization of the hepatic right lobe using a vessel sealing device (LigaSure™) for huge hepatic tumors with diaphragm invasion.

Authors:  Kenji Wakayama; Toshiya Kamiyama; Hideki Yokoo; Tatsuhiko Kakisaka; Tatsuya Orimo; Shingo Shimada; Yosuke Tsuruga; Hirofumi Kamachi; Akinobu Taketomi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

4.  Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.

Authors:  Yoshikuni Inokawa; Kenichi Inaoka; Fuminori Sonohara; Masamichi Hayashi; Mitsuro Kanda; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

5.  Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

Authors:  T T Zhang; X Q Zhao; Z Liu; Z Y Mao; L Bai
Journal:  Clin Transl Oncol       Date:  2015-11-17       Impact factor: 3.405

6.  Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.

Authors:  Shin Hwang; Jae-Won Joh; Hee Jung Wang; Dong Goo Kim; Kyung Sik Kim; Kyung-Suk Suh; Seong Hoon Kim; Hee Chul Yu; Chol Kyoon Cho; Young-Joo Lee; Ki-Hun Kim; Jong Man Kim; Bong-Wan Kim; Sung-Gyu Lee
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

7.  Surgical Outcomes for the Ruptured Hepatocellular Carcinoma: Multicenter Analysis with a Case-Controlled Study.

Authors:  Shogo Tanaka; Masaki Kaibori; Masaki Ueno; Hiroshi Wada; Fumitoshi Hirokawa; Takuya Nakai; Hiroya Iida; Hidetoshi Eguchi; Michihiro Hayashi; Shoji Kubo
Journal:  J Gastrointest Surg       Date:  2016-10-07       Impact factor: 3.452

8.  Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.

Authors:  Chao Wu; Xudong Ren; Quanbao Zhang
Journal:  Cancer Manag Res       Date:  2019-04-08       Impact factor: 3.989

9.  Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis.

Authors:  Yongjie Zhou; Xin Zhou; Jingqin Ma; Wen Zhang; Zhiping Yan; Jianjun Luo
Journal:  Cancer Manag Res       Date:  2021-03-01       Impact factor: 3.989

10.  Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.

Authors:  Takamichi Ishii; Takashi Ito; Shinji Sumiyoshi; Satoshi Ogiso; Ken Fukumitsu; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg Oncol       Date:  2020-12-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.